New collaboration aims to expand access to innovative immunology solutions.
- Mabtech partners with Sai Life Sciences.
- Expansion of Eyra multiplex immunology platform.
- Increased accessibility to immunology tools.
Mabtech has announced a new strategic collaboration with Sai Life Sciences to expand access to its Eyra multiplex immunology platform. This partnership aims to enhance the distribution and availability of advanced immunology tools. By working together, they hope to make these innovative solutions more accessible for researchers and healthcare providers in the United States.
Through this collaboration, Mabtech and Sai Life Sciences plan to leverage their respective expertise to improve the development and deployment of the Eyra platform. This initiative will support various applications within immunology, potentially benefiting researchers and companies focusing on disease diagnostics and therapeutic development. The partnership signifies a commitment to advancing research capabilities in the field of immunology.
The Eyra multiplex immunology platform is designed to facilitate comprehensive immunoassays with increased efficiency and accuracy. Mabtech's focus is on enhancing research outputs, while Sai Life Sciences will aid in broadening the platform's reach. This strategic collaboration aligns with the growing demand for sophisticated immunology solutions in the healthcare sector.
